IL6 and breast carcinoma: OSM promoted IL-6 secretion approximately 5-fold in MDA-MB-468 cells, ∼4-fold in MDA-MB-231 cells, and ∼4-fold in 4T1.2 mouse mammary carcinoma cells (Figure 4A).